These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18614760)

  • 1. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.
    Taylor PA; Ehrhardt MJ; Lees CJ; Panoskaltsis-Mortari A; Krieg AM; Sharpe AH; Murphy WJ; Serody JS; Hemmi H; Akira S; Levy RB; Blazar BR
    Blood; 2008 Oct; 112(8):3508-16. PubMed ID: 18614760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.
    Liu J; Guo YM; Onai N; Ohyagi H; Hirokawa M; Takahashi N; Tagawa H; Ubukawa K; Kobayashi I; Tezuka H; Minamiya Y; Ohteki T; Sawada K
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):627-636. PubMed ID: 26740374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum.
    Oluwole SF; Engelstad K; James T
    Blood; 1993 Mar; 81(6):1658-65. PubMed ID: 8453111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
    Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.
    Blazar BR; Taylor PA; Smith S; Vallera DA
    Blood; 1995 Feb; 85(3):842-51. PubMed ID: 7833486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.
    Blazar BR; Aukerman SL; Vallera DA
    Blood; 1992 Mar; 79(6):1636-42. PubMed ID: 1547353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.
    Ordemann R; Hutchinson R; Friedman J; Burakoff SJ; Reddy P; Duffner U; Braun TM; Liu C; Teshima T; Ferrara JL
    J Clin Invest; 2002 May; 109(9):1249-56. PubMed ID: 11994414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.
    Reddy P; Teshima T; Hildebrandt G; Williams DL; Liu C; Cooke KR; Ferrara JL
    Blood; 2003 Apr; 101(7):2877-85. PubMed ID: 12433681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model.
    Chen P; Aguilar OA; Rahim MM; Allan DS; Fine JH; Kirkham CL; Ma J; Tanaka M; Tu MM; Wight A; Kartsogiannis V; Gillespie MT; Makrigiannis AP; Carlyle JR
    J Immunol; 2015 Mar; 194(6):2909-18. PubMed ID: 25681346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens.
    Blazar BR; Taylor PA; Bluestone JA; Vallera DA
    Blood; 1996 May; 87(10):4463-72. PubMed ID: 8639809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
    Vallera DA; Taylor PA; Sprent J; Blazar BR
    Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.